miR-146a-mediated downregulation of IRAK1 is involved in a wide spectrum of diseases, including autoimmune disorders, cancer, diabetes, or neuropathic pain 54-57, as well as in cerebral, hepatic, or intestinal IRI 58-60. Here, IRAK1 is linked to diabetes mellitus.